NEW YORK (GenomeWeb) – VolitionRx announced today that it has signed a global sales and distribution agreement with Active Motif for a set of research-use-only kits, based on VolitionRx's Nucleosomics technology.

VolitionRx's RUO kits are based on the same Nu.Q immunoassay technology as the firm's cancer screening panels, and may be useful for exploring clinical questions beyond cancer biomarkers, the company said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Genetic ancestry testing can affect a person's sense of identity, the New York Times Magazine writes.

Nebula Genomics is launching its genome sequencing service for free for people who provide certain information about themselves, the Boston Globe reports.

In PLOS this week: grey wolf population genomics, mutations associated with lung adenocarcinoma survival, and more.

An opinion piece at Bloomberg discusses China's stance on genomic research.

Dec
03
Sponsored by
Advanced Cell Diagnostics

This webinar will demonstrate how a research team at the National Institutes of Health evaluated a novel in situ hybridization approach and applied it to study splice variants related to schizophrenia.